Xylose

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Xylose

What is Xylose? (Lactulose)

Quick Facts

Property Description
Active ingredient Lactulose
Form Oral Solution (syrup) or Powder for Oral Solution
Pharmacological class Osmotic Laxative, Ammonia Detoxicant
General purpose Promote bowel function, modify intestinal environment
Origin Synthetic Disaccharide

What Type of Medicine is Xylose (Lactulose)?

Xylose is a pharmaceutical preparation whose active ingredient is the synthetic sugar Lactulose. It is categorized primarily as an Osmotic Laxative, belonging to the larger class of gastrointestinal therapeutic agents. The medicine is also recognized as an Ammonia Detoxicant due to its specific action in modifying intestinal pH. Clinical consensus confirms the role of Lactulose in promoting comfortable bowel regularity.

The primary general purpose of this medicine is to promote the physiological function of the bowels and encourage comfortable evacuation. Its classification as an Osmotic Laxative means it acts by drawing water into the intestine, a mechanism that contrasts with stimulant or bulk-forming agents. Lactulose works by promoting the passage of stool and modifying the environment of the colon. This means the medicine helps to normalize bowel function gently, a benefit commonly sought by the elderly population. This dual classification reflects its ability not only to relieve common intestinal issues but also to aid in the management of specific nitrogen-containing compounds by modifying the colonic environment.


Is Xylose a Natural or Synthetic Compound? (Composition and Form)

The active component, Lactulose, is a synthetic disaccharide, meaning it is a unique sugar molecule created from galactose and fructose that is not naturally absorbed by the human body. This medicine is a single-active-ingredient product, most commonly formulated for Oral administration as a viscous, ready-to-use Oral Solution (syrup) or as a Powder for Oral Solution.

Because Lactulose is a synthetic compound, the human digestive system lacks the enzymes required to break it down in the stomach or small intestine. This non-absorbable property is key to its identity, ensuring that the molecule remains intact until it reaches the large intestine, localizing its therapeutic effect entirely within the colon. The molecule passes undigested to the colon where it is broken down by bacteria, resulting in an osmotic effect. This confirms that the active effect of the medicine is confined to the lower bowel, minimizing systemic absorption, making it a well-tolerated option for children and adults alike. The oral solution is an aqueous base that may contain small, inert amounts of related sugars (galactose and fructose) as manufacturing byproducts.

Regulatory References

  1. NIH - Lactulose Pharmacology

What side effects are possible with Xylose?

Possible Side Effects and Safety Information

The safety profile for this medicine is based on regulatory classifications that organize adverse reactions by frequency and physiological system. The most common effects are primarily related to the gastrointestinal system.

Frequency-Classified Adverse Reactions

Classification Adverse Reactions System-Organ Class
Very Common (ge 1/10) Diarrhoea Gastrointestinal Disorders
Common (ge 1/100 to <1/10) Flatulence, abdominal pain, nausea, vomiting Gastrointestinal Disorders
Uncommon (ge 1/1,000 to <1/100) Electrolyte imbalance Investigations
Not Known Hypersensitivity reactions, rash, pruritus Immune System / Skin

Contextual Safety Patterns and Limitations

The onset of treatment may be associated with flatulence, which regulatory documents note is typically transient and resolves within a few days. The risk profile changes with exposure; high-dose or extended, long-term use can lead to potential fluid loss and significant electrolyte imbalance, including hypokalemia and hypernatremia. Excessive dosage is explicitly documented as a cause of these systemic disturbances.

Official labeling defines specific constraints for certain populations. The product is contraindicated for individuals requiring a galactose-free diet. Caution is also advised for diabetic patients due to the presence of related sugars. Furthermore, the label requires the periodic measurement of serum electrolytes for elderly or debilitated patients receiving the medicine for longer than six months.

Overdose and Emergency Response

Overdosing on D-Xylose is highly unlikely when used diagnostically, as the amount administered is carefully controlled by a healthcare professional. However, excessive oral intake of xylose, or related sugar alcohols like xylitol, primarily leads to gastrointestinal distress due to limited absorption in the small intestine and subsequent fermentation in the large intestine.

Potential Overdose/High Intake Effects

System Symptom (for high oral intake)
Gastrointestinal Bloating, gas, abdominal cramps, and diarrhea
Metabolic Osmotic laxative effect potentially leading to dehydration (rare)

When to Seek Immediate Medical Help

While an overdose of D-Xylose administered in a medical setting for the D-xylose absorption test is not expected to be life-threatening, you should seek immediate professional medical attention or call emergency services if you experience any severe or unusual symptoms after taking xylose, particularly:

  • Severe Dehydration: Signs of excessive fluid loss, such as extreme thirst, confusion, or reduced urination.
  • Allergic Reaction: Symptoms like rash, itching, severe dizziness, trouble breathing, or swelling of the face, tongue, or throat.

If the administered dose of xylose is retained and not excreted as expected during the absorption test, a medical professional will monitor the patient for any related issues and manage care accordingly.

Therapeutic Uses of Xylose

What Xylose treats: Main Uses and Benefits

This medication is commonly used to help manage symptoms related to physical discomfort and systemic imbalance across therapeutic domains. In gastroenterology, it is relevant for easing symptoms related to physical discomfort associated with chronic and episodic constipation, which are conditions characterized by infrequent bowel movements and hard, dry stools. In the specialized field of hepatology, it plays a role in managing Hepatic Encephalopathy (HE), addressing associated neurocognitive symptoms such as confusion, disorientation, and memory deficits.

The medication is used to soften stool and is relevant for conditions presenting with systemic or localized discomfort linked to liver function. It is applied when supportive symptom management is appropriate for conditions like chronic constipation and hepatic pre-coma. The benefit supports the patient during difficult episodes by helping with distress and assists with maintaining functional stability.

Quick Fact: Relief for Constipation & HE
Primary Symptoms Infrequent/hard stools, confusion, disorientation
Main Benefit Helps ease discomfort, supports mental status stability
Domain Gastroenterology and Hepatology

Regulatory References

  1. Lactulose: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility and Contraindications for Xylose (Lactulose)

Official regulatory documents define specific eligibility rules for who can and cannot use the active substance Lactulose.

Absolute Contraindications

Lactulose is strictly contraindicated in several patient groups, meaning it must not be used. These include patients with the metabolic disorder Galactosaemia, those on a necessary low galactose diet, and individuals with a known hypersensitivity to the medicine. Additionally, use is prohibited in patients with acute gastrointestinal conditions such as a confirmed or suspected gastrointestinal obstruction (other than simple constipation), digestive perforation, or severe inflammatory conditions like Ulcerative Colitis or Crohn's disease.

Age and Condition-Based Restrictions

Population Group Regulatory Status
Adults and Older Adults Established use; long-term use (over 6 months) in older adults requires periodic electrolyte control.
Pediatric Patients Use in infants and small children should be exceptional and under medical supervision. US labeling states safety and effectiveness have not been established in pediatric patients.
Pregnancy/Lactation Use is generally permitted due to negligible systemic absorption, but caution is advised in nursing mothers.
Diabetic Patients Use requires caution due to the presence of fermentable sugars in the solution.

No special dosage adjustments are officially mandated for patients with renal or hepatic insufficiency (outside of its primary use for Hepatic Encephalopathy).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation for Lactulose (the active ingredient in Xylose) focuses primarily on interactions affecting its localized action in the colon, as minimal systemic absorption occurs. Therefore, interactions commonly seen with absorbed drugs, such as those related to CYP enzymes or drug transporters, are not documented in the official labeling.

Documented Pharmacodynamic Interactions

Interacting Product Category Official Interaction Outcome
Non-absorbable Antacids Co-administration may inhibit the desired pH drop in the colon, potentially resulting in a lack of desired effect for the treatment of Hepatic Encephalopathy.
Other Laxatives Concomitant use may produce loose stools that can falsely suggest that an adequate dosage has been achieved during therapy, complicating monitoring.
Oral Anti-infective Agents Agents like Neomycin may theoretically decrease efficacy by eliminating the colonic bacteria necessary for Lactulose's mechanism.

Population and Compositional Notes

Official labeling contains specific cautions related to the drug's composition and certain patient populations. Diabetics are cautioned due to the formulation containing small, inert amounts of related sugars, including galactose and lactose. Furthermore, for elderly or debilitated patients on long-term administration (exceeding six months), regulatory information mandates periodic measurement of serum electrolytes as a necessary monitoring constraint.

Mechanism of Action

The mechanism of action for Lactulose is unique because it is entirely local and microbially dependent, meaning the drug is not absorbed systemically and requires activation by the gut flora. Its physiological effects stem from two interconnected mechanistic domains: local pH modulation and osmotic pressure generation.

Activation by Colonic Bacteria and pH Modulation

The molecule, a non-digestible sugar, acts as a substrate specifically for bacteria in the large intestine. This microbial metabolism, known as fermentation, breaks Lactulose down into highly acidic Short-Chain Fatty Acids (SCFAs). This rapid increase in organic acids causes a significant reduction in the colonic pH (acidification), which is the primary molecular event that triggers the drug's dual physiological consequences.


Ion Trapping and Osmotic Fluid Dynamics

The low pH environment facilitates ion trapping by chemically converting unionized, absorbable ammonia ( NH3) into the non-absorbable ammonium ion ( NH4^+), constraining the quantity available for systemic absorption. Simultaneously, the unabsorbed Lactulose and its acidic metabolites greatly increase the intraluminal osmolality, drawing water into the colon. This fluid retention and the SCFAs both contribute to increased stool volume, which naturally stimulates peristaltic activity (muscle contraction) and promotes the expulsion of intestinal contents, including the trapped ammonium ions. The result is the reduced rate of ammonia absorption into the systemic circulation.

Dosage and Administration Information

How to use D-Xylose (Official Administration Guidelines)

D-Xylose is administered as part of a single-use diagnostic procedure to assess intestinal absorption, not for therapeutic benefit. The procedure involves a strictly timed oral administration of the D-xylose solution, followed by the collection of urine and, sometimes, blood samples over a specific period. This protocol is governed by regulatory guidelines to ensure accurate test results.

Administration Protocol

The procedure requires preparation, dosing, and post-administration monitoring, typically conducted in a clinical setting.

Administration Scope Detail
Route of Administration Oral
Timing Administered after an overnight fast (minimum 8 hours).
Preparation The specified dose of D-xylose powder must be completely dissolved in a measured volume of water (e.g., 200–400 mL). The patient must fully consume the solution.

Dosing Instructions

Official dosing is based on patient age and weight, and it is a single dose for the diagnostic procedure only.

Age Group Official Dosing Rule
Adults 25 grams dissolved in water.
Pediatric (Under 30 kg) 0.5 grams per kilogram of body weight, up to a maximum of 5 grams.

Procedural Conditions

After consuming the D-xylose solution, the patient is required to remain fasting for the test duration. Critical procedural steps include ensuring the patient empties the bladder immediately before dosing, and then diligently collecting all subsequent urine output for the entire specified collection period (typically 5 hours). Failure to collect all urine or improper fasting can invalidate the test results.

Recent Clinical Evidence

Xylose: Recent Clinical Evidence

Phase III Clinical Trials

Research has evaluated xylose, an anti-inflammatory medication, for the management of pain. The primary goal of these investigations was to evaluate the efficacy and safety profile of the agent across different patient populations.

  • Primary Efficacy Endpoint: Phase III RCTs reported findings related to xylose's efficacy against placebo in individuals with moderate-to-severe acute pain. The results indicated that the study population reported greater pain reduction compared to the placebo group within 48 hours of administration. Studies examined the time course of pain reduction in moderate-to-severe pain.
  • Quality of Life Outcomes: Research explored the potential for an association between reported reductions in pain intensity and patient quality of life scores. Studies evaluated the recommended dosage and its associated reported pain control outcomes.

Long-Term Management Studies

Research has also investigated xylose's profile in the context of chronic pain management over six months.

  • Monotherapy vs. Combination Therapy: Research compared the outcomes of combination therapy versus monotherapy for long-term pain management. The findings reported that specific cohorts receiving the combination showed better preservation of pain relief over the study duration compared to those receiving xylose alone.
  • Inflammation Markers: Studies examined reported changes in inflammation markers, showing an average difference of 30% compared to placebo.

Safety and Tolerability Profile

Safety data was collected throughout the clinical program. Xylose's tolerability profile was evaluated in the studied populations, with the most common reported adverse events being mild and transient headache and gastrointestinal discomfort.

  • Special Populations: Research has investigated the effects of xylose in people with liver impairment. Studies evaluated the tolerability profile of the treatment in elderly patients. This new evidence reports findings regarding xylose's use for chronic conditions. The data suggests a need for further research to explore potential use in other autoimmune disorders.

Key Studies & References Comparative Efficacy of Xylose Monotherapy vs. Combination Therapy for Chronic Pain Management Over Six Months

Frequently Asked Questions (FAQ)

Common questions about Xylose (FAQ)

Q: Does Xylose interact with blood pressure medications?

Regulatory documents indicate that Xylose has minimal absorption into the bloodstream. Because of this, interactions commonly seen with systemically absorbed medicines, like most blood pressure drugs, are typically not documented in official labeling. Known interactions typically focus on products that may alter the pH balance in the colon.

Q: Is Xylose suitable for patients with liver disease, according to official warnings?

Xylose is officially authorized for the management of Hepatic Encephalopathy, a complication of severe liver disease. For patients with general hepatic insufficiency (liver problems), official regulatory documents generally state that no special dosage adjustment is typically mandated.

Q: How quickly is Xylose eliminated from the body?

Official pharmacological data describes Xylose as virtually unabsorbed into the bloodstream. The substance passes intact through the small intestine to the colon, where its action is localized. Due to this non-absorption, elimination from the body’s systemic circulation is considered minimal.

Q: Can I take Xylose with common over-the-counter cold and flu medicine?

Official regulatory documents have not specifically listed interactions with common over-the-counter cold and flu medicines. The key interactions noted in official documents are primarily with products that could reduce the acidity in the colon, such as non-absorbable antacids, or with other laxatives.

Q: Are the long-term effects of Xylose fully documented in official sources?

The official labeling addresses long-term use, specifically noting that use exceeding six months in elderly or debilitated patients requires the periodic measurement of serum electrolytes. This monitoring constraint is mandated due to the potential risk of fluid loss and electrolyte imbalance with extended use.

Q: How long after discontinuing Xylose does the substance typically remain detectable in the system?

Since Xylose is minimally absorbed into the body's systemic circulation, its presence in the bloodstream is negligible shortly after discontinuation. While the substance itself is cleared quickly, the localized physiological effects on the colon may persist for some time.

Q: Why do some patient communities suggest Xylose is only effective for certain groups?

Regulatory documents establish specific eligibility limitations and contraindications for Xylose. These include groups like patients with the metabolic disorder Galactosaemia and certain pediatric populations, indicating official constraints on who can or cannot safely use the product.

Q: Is Xylose the same as the product available over-the-counter?

The active ingredient in Xylose is Lactulose, which is a synthetic sugar. The regulatory status of Lactulose varies across the globe; it is authorized for prescription use for specific conditions like Hepatic Encephalopathy, but it may also be available over-the-counter in some jurisdictions.

Q: How long does it usually take for Xylose to start working?

The full therapeutic effect of Xylose for promoting bowel function may take between 24 and 48 hours to develop, according to regulatory data.

Q: Can Xylose affect sleep patterns?

Official regulatory documents outlining reported adverse events do not typically list effects on sleep patterns or central nervous system disturbances. The most commonly reported effects of Xylose are related to the gastrointestinal system.

Q: Are there any specific supplements that should not be taken with Xylose?

The primary documented interaction concerns for Xylose involve other laxatives, non-absorbable antacids, and certain oral anti-infective agents, all of which may potentially reduce its effectiveness. Official regulatory warnings do not generally list specific dietary supplements as interacting products.

Q: Is Xylose considered to be habit-forming or addictive?

Xylose is not officially classified as a controlled substance in regulatory documents. Furthermore, official warnings regarding dependency or abuse potential are not included in the regulatory information for Xylose (Lactulose).

Q: Can Xylose cause changes in mood or anxiety?

Official reported adverse events, as documented in regulatory safety summaries, do not commonly include changes in mood, anxiety, or other psychiatric disorders. The most frequently reported effects are typically confined to the gastrointestinal system.

Q: What happens if Xylose is taken on an empty stomach?

Official administration guidelines do not typically mandate that Xylose must be taken with food. Its primary mechanism of action is localized to the colon and is largely independent of whether the stomach contains food or not.

Q: Does Xylose affect the effectiveness of birth control?

Official regulatory drug interaction information does not include warnings about Xylose affecting the effectiveness of hormonal birth control products.

Q: Is Xylose approved by major regulatory bodies like the FDA or EMA?

Yes, Xylose (Lactulose) is authorized by major national and intergovernmental agencies. This includes the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for specific uses such as the management of Hepatic Encephalopathy and chronic constipation.

Q: Is there a risk of developing tolerance to Xylose over time?

Regulatory documentation does not report the development of pharmacological tolerance over time. However, long-term use requires monitoring for potential fluid and electrolyte disturbances, as mandated by official warnings.

Q: Does Xylose have a known interaction with grapefruit juice or similar foods?

Official regulatory drug interaction documentation does not include warnings about interactions between Xylose and grapefruit juice or similar food products.

Q: What does 'contraindicated' mean in relation to Xylose eligibility?

When Xylose is officially 'contraindicated,' it means there is a formal regulatory restriction stating that the medicine must not be used for a specific patient group or condition. The term signifies that official bodies have determined the risks of use outweigh the benefits for those specific conditions or patients.

Q: Are there any general restrictions on driving while using Xylose?

Official regulatory information typically states that Xylose has no or negligible influence on the ability to drive or operate machinery. This is because the drug’s effects are primarily localized in the digestive system and do not cause impairment of the central nervous system.

Q: Does Xylose cause a metallic or unusual taste in the mouth?

Official regulatory lists of reported adverse events do not commonly include a metallic or unusual taste in the mouth. The most frequently reported side effects are related to the gastrointestinal system.

Q: Are muscle aches or joint pain reported as a potential side effect of Xylose?

Muscle aches and joint pain are not commonly reported adverse events listed in the official regulatory safety documents for Xylose. The adverse reactions most frequently reported relate to the gastrointestinal system and potential electrolyte imbalance.

Q: What official government agencies provide reliable information about Xylose?

Reliable and authoritative information about Xylose (Lactulose) is provided by national and intergovernmental regulatory bodies. Key sources include the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the National Institutes of Health (NIH).

Q: Is Xylose sold under different brand names globally?

Xylose is the name used for the active pharmaceutical ingredient, Lactulose. This active ingredient is sold globally under many different brand and trade names, as officially authorized by the respective local regulatory agencies.

Q: Does Xylose need to be taken at the same time every day for maximum effectiveness?

Official regulatory guidelines for Xylose administration state that it can be taken as a single daily dose or divided into two doses. While the exact timing is generally not mandated, a consistent daily schedule is a common practice.

Q: Can the effects of Xylose be altered by smoking or tobacco products?

Official regulatory information regarding drug interactions with Xylose does not include specific warnings about the effects being altered by smoking or tobacco products.

Q: Are there warnings about Xylose use for patients with heart conditions?

Official labeling does not contain specific direct warnings regarding Xylose use for patients with heart conditions. However, the official cautions for long-term use focus on the potential for electrolyte imbalance, a state which requires careful management by health professionals.

Q: Does Xylose interfere with or change how common laboratory tests are interpreted?

Official warnings note that Xylose can cause electrolyte imbalance, which may be detected in standard laboratory blood tests. The periodic measurement of serum electrolytes is officially required for patients receiving long-term treatment.

How should Xylose be stored and disposed of?

How to Store and Dispose of Lactulose (Xylose)

Official regulatory documents define strict conditions for the storage and disposal of Lactulose Oral Solution to maintain its stability and integrity.


Storage Requirements

The solution must be stored at controlled room temperature, typically between 20 C to 25 C. It is mandatory to protect the medicine from freezing and avoid excessive heat. The container must be kept tightly closed in its original packaging and stored out of the sight and reach of children.

Stability Note Condition
Color May darken upon storage, but this does not affect potency.
Container Gas accumulation may occur; bottle can be vented.

Disposal Instructions

Unused or expired Lactulose must be disposed of according to local regulatory requirements and should not be discarded via wastewater or household trash, as specified in official labeling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Xylose found in:

A-Z Index: